27
Apr
2008
27
Apr
2008
Posted in I - Series D, Q - 1Q08, R - MID WEST, X - Device (Dialysis)
GraftCath (Coon Rapids, MN) a commercialization stage medical device company focused on reducing infections for dialysis patients closed a $11.8M Series D financing. Participants include Affinity Capital Management, Ascension Health Ventures, Cutlass Capital, Sapient Capital and Three Arch Partners.
05
Feb
2008
02
Apr
2007
Endocyte (West Lafayette, IN) developer of folate-targeted based therapeutics for the treatment of renal cell carcinoma, ovarian, endometrial and nscl cancer raised $15M in a Series C financing. Participants included Sanderling Ventures, Burrill & Company, Triathlon Medical Ventures, Blue Chip Venture Company, American Bailey Ventures and CID Capital.
26
Mar
2007
20
Feb
2007
17
Jan
2007
14
Dec
2006